Status:
COMPLETED
Relaxation Response Training to Treat Hypertension
Lead Sponsor:
Massachusetts General Hospital
Collaborating Sponsors:
Brigham and Women's Hospital
Conditions:
Hypertension
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Interventions such as Relaxation Response appear to have widespread effects on physiology. Endothelial function, changes in genomic expression, several biomarkers have been associated with chronic str...
Eligibility Criteria
Inclusion
- General Inclusion Criteria:
- Healthy men and women
- Hypertension (stage 1)
- 18-70 years old
- General Exclusion Criteria
- No asthma or nasal allergies
- Non-smokers
- If on anti-hypertensive medication willing to discontinue
- Cannot currently practice Tai Chi, meditation, or yoga regularly
- Current use of the following medications: phosphodiesterase type 5 inhibitors, long-acting nitrates, systemic corticosteroids, anti-inflammatories, immunosuppressive or cytotoxic therapies (currently or within the last 12 months), anabolic steroids, and antidepressants.
Exclusion
Key Trial Info
Start Date :
April 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2011
Estimated Enrollment :
58 Patients enrolled
Trial Details
Trial ID
NCT01263743
Start Date
April 1 2009
End Date
June 1 2011
Last Update
April 19 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Massachusetts General Hospital
Boston, Massachusetts, United States, 02114